Marathon sells Duchenne drug to PTCPTC says it will make changes to the price after abandoned launch last month. Share XMarathon sells Duchenne drug to PTChttps://pharmaphorum.com/transversal-categories/rare-diseases/marathon-sells-duchenne-drug-ptc/
Marathon halts launch of Duchenne drug after price outcryCompany says it will listen to concerns of patient advocates Share XMarathon halts launch of Duchenne drug after price outcryhttps://pharmaphorum.com/news/marathon-halts-launch-duchenne-drug-price-outcry/